Can’t find a document?
Request Information
NI-G1022 : Nicaragua - Regional Malaria Elimination Initiative (IREM) in Mesoamerica and Dominican Republic
Project Status: Implementation
Support technically and financially to Nicaragua to co-finance investment in health, in the areas with the highest incidence of Malaria, to implement cost-effective interventions that lead to elimination under a results-based financing scheme.
Project Detail
Project Number
NI-G1022
Approval date
March 27, 2019
Project Country
Nicaragua
Project Sector
HEALTH
Project Subsector
DISEASE PREVENTION & CONTROL
Project Type
Investment Grants
Environmental and social impact category
C
Project Status
Implementation
Operation Number
GRT/MM-17275-NI
Financial Information
Project Number
NI-G1022
Project Status
Implementation
IDB Financing
Financing type
GRT
Fund
Malaria Elimination Blending Facility
Reporting currency
USD - United States Dollar
Reporting date
Jun/24/2022
Roles & Responsibilities
Contract signature date
Apr/10/2019
Operation Number
GRT/MM-17274-NI
Financial Information
Project Number
NI-G1022
Project Status
Implementation
IDB Financing
Financing type
GRT
Fund
Malaria Elimination Blending Facility
Reporting currency
USD - United States Dollar
Reporting date
Jun/24/2022
Roles & Responsibilities
Contract signature date
Apr/10/2019
Project Information
Total Cost
USD 14,950,000
Country counterpart financing
USD 9,750,000
Amount
USD 5,200,000
Preparation
Title
Type
Project Number
Date Published
Project Profile
NI-G1022
December 13, 2018
Approved
Title
Type
Project Number
Date Published
General Agreement
NI-G1022
June 04, 2019
Implementation
Title
Type
Project Number
Date Published
Annual Project Audited Financial Statement
NI-G1022
June 15, 2022
Annual Project Audited Financial Statement
NI-G1022
November 30, 2021
Specific Procurement Notices
NI-G1022
September 10, 2020
Specific Procurement Notices
NI-G1022
May 12, 2020
General Procurement Notices
NI-G1022
April 03, 2020
Procurement Information
DATA ACCESS AND LICENSING
Except where otherwise noted, content on this website is licensed under a Creative Commons Attribution 3.0 IGO (CC BY 3.0 IGO) https://creativecommons.org/licenses/by/3.0/igo/